Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 631.00 GBp
Change Today +8.50 / 1.37%
Volume 841.6K
BTG On Other Exchanges
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dame Pamela Louise Makin MA, Ph.D.(Cantab), MBA, DBE

Chief Executive Officer and Executive Director,BTG plc
AgeTotal Calculated CompensationThis person is connected to 20 board members in 3 different organizations across 4 different industries.

See Board Relationships
541,613,000 GBP
As of Fiscal Year 2015


Dr. Dame Pamela Louise Makin, MA, PhD (Cantab), MBA, DBE, has been the Chief Executive Officer of BTG PLC since September 17, 2004. Dr. Makin served as the President for Biopharmaceuticals Europe of Baxter Healthcare since 2001, where she was responsible for sales revenues in excess of a billion dollars from Europe, Africa and the Middle East and for several hundred employees. Dr. Makin joined Baxter Healthcare in 2000 as Vice President of Strategy and Business Development ...

Read Full Background

Corporate Headquarters*

5 Fleet Place
London, Greater London EC4M 7RD

United Kingdom

Phone: 44 20 7575 0000
Fax: 44 20 7575 0010

Board Members Memberships*

Chief Executive Officer and Executive Director
Non-Executive Director and Member of Remuneration Committee


University of Cambridge
University of Cambridge
University of Cambridge

Other Affiliations*

Annual Compensation*

Salary569,000 GBP
Bonus509,000 GBP
Total Annual Compensation1,078,000 GBP

Stock Options*

Long Term Incentive Plan402,000 GBP
All Other Compensation133,000 GBP
Exercised Options10,858
Exercised Options Value38,652 GBP
Exercisable Options539,752
Exercisable Options Value2,664,339 GBP
Unexercisable Options126,820
Unexercisable Options Value416,738 GBP
Total Value of Options3,119,729 GBP
Total Number of Options677,430

Total Compensation*

Total Annual Cash Compensation1,211,000 GBP
Total Short Term Compensation1,078,000 GBP
Other Long Term Compensation133,000 GBP
Total Calculated Compensation1,613,000 GBP
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTG:LN 631.00 GBp +8.50


Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
Fred P. Lampropoulos Chairman of The Board, Chief Executive Officer and President
Merit Medical Systems, Inc.
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
John A. Amster Co-Founder, Chief Executive Officer, President and Director
RPX Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BTG PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at